|
Mr. Lanzafame has over fifteen years experience in the medical device industry. With a background that includes chemical and industrial engineering, Mr. Lanzafame combines a strong technical background with extensive experience in business development and executive-level management. Until early 2004, Mr. Lanzafame was employed by STS Biopolymers, Inc., a privately held medical device company that marketed high performance polymer-based coatings for the medical device industry, including drug-eluting surfaces for devices such as coronary stents and indwelling catheters. Mr. Lanzafame held a variety of positions with STS Biopolymers, including positions in research, product development, and sales and marketing, and was President of STS Biopolymers at the time of the company's sale to Angiotech Pharmaceuticals in 2003. Mr. Lanzafame joined Biophan Technologies, Inc. in 2004 and currently serves as Chief Operating Officer and Vice President, Business Development, leading operations and business development activities for the company. | 